RxDoctor Payments Data

Sandy Webb, MD

Family Medicine · Palestine, TXNPI 1669933693

Payments from drug & device makers

$687in general payments, 2019–2025

Across 31 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$193
  • Novo Nordisk$153
  • Pfizer$90
  • Otsuka America Pharmaceutical, Inc.$85
  • AbbVie$60
  • Xeris Pharmaceuticals, Inc.$34
  • plus $71 from 3 others

What the payments were for

  • Food & beverage$64293%
  • Education$457%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$687 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$47,274
Medicare patients
135
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$156,313
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$77,523
JardianceEmpagliflozin75$76,262
MounjaroTirzepatide46$53,274
TrulicityDulaglutide29$29,576
Synjardy XrEmpagliflozin/Metformin Hcl22$29,301
FarxigaDapagliflozin Propanediol26$23,354
JanuviaSitagliptin Phosphate17$23,237
EliquisApixaban39$19,789
XareltoRivaroxaban18$16,038
Tresiba Flextouch U-200Insulin Degludec11$7,908
Spiriva HandihalerTiotropium Bromide11$7,734
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$5,862
Gabapentin181$3,488
Albuterol Sulfate HfaAlbuterol Sulfate145$2,916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$153$156,313129 claims
Lilly USA, LLCMounjaro, Trulicity$193$82,84975 claims
PfizerEliquis$90$19,78939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Palestine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →